MCK vs PETS · P/E 20, rev $403.43B vs rev $227.0M
McKesson Corporation (MCK) versus PetMed Express Inc (PETS) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
PetMed Express Inc (PETS) is a pharmaceutical retailers company listed on NASDAQ.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported PETS revenue for 2025-03-31 was $227.0M. Net income was -$6.3M. PETS currently screens at market cap $38.5M.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. PETS currently screens at market cap $38.5M.
Not investment advice. Open the MCK and PETS stock pages for the full models.
Not investment advice.